These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

851 related items for PubMed ID: 11684748

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD, Kaiser CJ, Kennedy JS, Sutton VK, Tran PV, Tollefson GD, Zhang F, Breier A.
    J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
    Kinon BJ, Basson BR, Gilmore JA, Malcolm S, Stauffer VL.
    J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
    [Abstract] [Full Text] [Related]

  • 28. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M, Kuloglu M, Tezcan E, Ustundag B.
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [Abstract] [Full Text] [Related]

  • 29. The psychosis of schizophrenia: prevalence, response to atypical antipsychotics, and prediction of outcome.
    Breier A, Berg PH.
    Biol Psychiatry; 1999 Aug 01; 46(3):361-4. PubMed ID: 10435201
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The effects of novel antipsychotics on glucose and lipid levels.
    Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC.
    J Clin Psychiatry; 2002 Oct 01; 63(10):856-65. PubMed ID: 12416594
    [Abstract] [Full Text] [Related]

  • 32. Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.
    Gureje O, Miles W, Keks N, Grainger D, Lambert T, McGrath J, Tran P, Catts S, Fraser A, Hustig H, Andersen S, Crawford AM.
    Schizophr Res; 2003 Jun 01; 61(2-3):303-14. PubMed ID: 12729882
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.
    Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD.
    Arch Gen Psychiatry; 2000 Mar 01; 57(3):249-58. PubMed ID: 10711911
    [Abstract] [Full Text] [Related]

  • 35. Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol.
    Purdon SE, Woodward N, Lindborg SR, Stip E.
    Psychopharmacology (Berl); 2003 Sep 01; 169(3-4):390-7. PubMed ID: 12827347
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol.
    Le Pen G, Moreau JL.
    Neuropsychopharmacology; 2002 Jul 01; 27(1):1-11. PubMed ID: 12062902
    [Abstract] [Full Text] [Related]

  • 38. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI, Czobor P, Nolan KA.
    J Clin Psychopharmacol; 2008 Oct 01; 28(5):485-93. PubMed ID: 18794642
    [Abstract] [Full Text] [Related]

  • 39. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
    Casey DE, Daniel DG, Wassef AA, Tracy KA, Wozniak P, Sommerville KW.
    Neuropsychopharmacology; 2003 Jan 01; 28(1):182-92. PubMed ID: 12496955
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.
    J Psychiatr Res; 2006 Oct 01; 40(7):669-76. PubMed ID: 16762371
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.